tiprankstipranks
Trending News
More News >
Adaptimmune Therapeutics (ADAPY)
OTHER OTC:ADAPY
US Market

Adaptimmune Therapeutics (ADAPY) Cash flow

Compare
1,278 Followers

Adaptimmune Therapeutics Cash Flow

ADAPY's free cash flow for Q2 2025 was $-34.85M. For the 2025 fiscal year, ADAPY's free cash flow was decreased by $69.83M and operating cash flow was $-34.78M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -73.21M$ -140.88M$ -141.77M$ 10.73M$ -53.59M
Investing Cash Flow
$ -58.95M$ 176.54M$ 89.14M$ 75.80M$ -278.92M
Financing Cash Flow
$ 78.75M$ 880.00K$ 12.87M$ 3.29M$ 340.05M
End Cash Position
$ 93.21M$ 147.02M$ 109.60M$ 151.67M$ 61.48M
Free Cash Flow
$ -75.93M$ -145.76M$ -171.51M$ 1.95M$ -56.50M
Currency in USD

Adaptimmune Therapeutics Cash Flow